Chemicals and pharmaceuticals · EVOK

Evoke Pharma Inc

9 filings mentioning 7 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

9filings we hold
7topics disclosed
Chemicals and pharmaceuticalsindustry
CAbased in

Across 9 filings we hold, Evoke Pharma Inc has written down 7 of the topics we track. That places it 469 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

EVOK Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something Evoke Pharma Inc has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO 27001:202242
ISO 37001:201639
ASD Strategies to Mitigate Cyber Security Incidents29
ISO 3700126
GDPR26
ISO/IEC 27701:201921
Code of Conduct on Data Protection for Research (GDPR Article 40)12
HIPAA Security Rule10
COSO Internal Control9

10 frameworks, 292 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Restatement4
Internal Control3
Enforcement Action3
Material Weakness2
Regulatory Reporting1
Ransomware1
Data Breach1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Restatement42025-12-17
Internal Control32024-05-14
Enforcement Action32025-11-04
Material Weakness22024-05-14
Regulatory Reporting12020-05-12
Ransomware12024-05-14
Data Breach12025-11-04

When it filed

Filings we hold, by year. Hover a bar for the count.

20
21
22
23
24
25

Recent filings

FiledFormItem
2025-12-178-KCompletion of an acquisition, Delisting or listing rule failure, Item 3.03filing
2025-11-048-KEntry into a material agreement, Director or officer departure, Other material eventfiling
2024-05-288-KDirector or officer departure, Item 5.03, Shareholder votefiling
2024-05-1410-K/Afiling
2024-05-148-KFinancial statements no longer reliablefiling
2024-02-098-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2023-05-118-KDirector or officer departure, Shareholder vote, Financial statements and exhibitsfiling
2021-01-148-KOther material event, Financial statements and exhibitsfiling
2020-05-1210-Qfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition